RESUMO
ABSTRACT: The enormous inroads made by renewable energy in recent years have been the key to the development of new technologies designed to obtain energy from a range of resources. Hydrokinetic microturbines used to harness kinetic energy from rivers, tidal and marine currents epitomize such developments. As the reservoir is dispensed with, the water footprint normally associated with conventional hydroelectric generation is minimized. The new prototypes being developed require laboratories with water tunnel infrastructures where they can be accurately reproduced under controlled conditions. However, the construction of a water tunnel demands considerable investment, which prevents many research groups from completing their prototype design work. This paper charts the design of a low-cost hydrodynamic water tunnel at the University of Oviedo, indicating the mechanical and electronic elements as well as the software developments that make up the facility. This construction is a part of a research strategy focused on making the study of new hydrokinetic microturbines designs economically feasible. Moreover, it includes a description of a special software application used to perform the characterization of a hydrokinetic microturbine model in the water tunnel and a demonstration of the scope of the facility in the experimental study of a unit with a Darrieus rotor.
RESUMO
BACKGROUND: The purpose of this prospective cohort study was to compare the costs of day hospital (DH) care for hyperglycemic crisis in elderly diabetic patients with those of conventional hospitalization (CH). Secondary objectives were to compare these two clinical scenarios in terms of glycemic control, number of emergency and outpatient visits, readmissions, hypoglycemic episodes, and nosocomial morbidity. METHODS: The study population comprised diabetic patients aged >74 years consecutively admitted to a tertiary teaching hospital in Spain for hyperglycemic crisis (sustained hyperglycemia [>300 mg/dL] for at least 3 days with or without ketosis). The patients were assigned to DH or CH care according to time of admission and were followed for 6 months after discharge. Exclusion criteria were ketoacidosis, hyperosmolar crisis, hemodynamic instability, severe intercurrent illness, social deprivation, or Katz index >D. RESULTS: Sixty-four diabetic patients on DH care and 36 on CH care were included, with no differences in baseline characteristics. The average cost per patient was 1,345.1±793.6 in the DH group and 2,212.4±982.5 in the CH group (P<0.001). There were no differences in number of subjects with mild hypoglycemia during follow-up (45.3% DH versus 33.3% CH, P=0.24), nor in the percentage of patients achieving a glycated hemoglobin (HbA(1c)) <8% (67.2% DH versus 58.3% CH, P=0.375). Readmissions for hyperglycemic crisis and pressure ulcer rates were significantly higher in the CH group. CONCLUSION: DH care for hyperglycemic crises is more cost-effective than CH care, with a net saving of 1,418.4 per case, lower number of readmissions and pressure ulcer rates, and similar short-term glycemic control and hypoglycemia rates.
